眼睑恶性肿瘤组织中P53蛋白及增殖细胞核抗原表达的研究

目的 探讨Ｐ５３基因突变与眼睑恶性肿瘤发生的关系。方法 采用链霉卵白素－生物素（ＬＳＡＢ）免疫组化方法检测１０２例眼睑恶性肿瘤组织Ｐ５３蛋白及增殖细胞核抗原（ＰＣＮＡ）表达情况。结果 在正常眼睑皮肤、睑板腺及轻度不典型增生眼睑上皮中,未见Ｐ５３蛋白表达,而中、重度不典型增生,原位癌,浸润癌中,Ｐ５３蛋白阳性表达率逐渐增高,其ＰＣＮＡ指数也有增加趋势。３０／５３例基底细胞癌（ＢＣＣ）、１６／３２例鳞     

翼状胬肉中核糖体S6蛋白磷酸化、细胞周期蛋白D1的表达及意义

目的　研究核糖体Ｓ６蛋白磷酸化（ｒｉｂｏｓｏｍａｌＳ６ｐｒｏｔｅｉｎｐｈｏｓｐｈｏｒｙｌａｔｉｏｎ,Ｐ-Ｓ６）和细胞周期蛋白Ｄ１（ＣｙｃｌｉｎＤ１）在翼状胬肉中的表达及相关性,探讨哺乳动物雷帕霉素靶蛋白复合物１（ｍａｍｍａｌｉａｎｔａｒｇｅｔｏｆｒａｐａｍｙｃｉｎｃｏｍｐｌｅｘ１,ｍＴＯＲＣ１）信号通路在翼状胬肉发病机制中的作用。方法　收集翼状胬肉组织３１例,正常结膜组织１７例,利用免疫组织化学和Ｗｅｓｔｅｒｎｂｌｏｔ进行Ｐ-Ｓ６和ＣｙｃｌｉｎＤ１的检测及比较。结果　Ｗｅｓｔｅｒｎｂｌｏｔ检测６例翼状胬肉组织中Ｐ-Ｓ６蛋白／Ｓ６蛋白表达（１．１９６±０．１０１）显著高于正常结膜组织（０．２９５±０．０５６）,差异有统计学意义（Ｐ＜０．０５）。免疫组织化学染色结果显示:翼状胬肉中Ｐ-Ｓ６、ＣｙｃｌｉｎＤ１的阳性表达率均为１００％（２５／２５）,正常结膜组织中Ｐ-Ｓ６阳性表达率为１８．２％（２／１１）、ＣｙｃｌｉｎＤ１阳性表达率为９．１％（１／１１）,正常结膜组织与翼状胬肉组织中Ｐ-Ｓ６与ＣｙｃｌｉｎＤ１表达差异均有统计学意义（均为Ｐ＜０．０５）。翼状胬肉组织中Ｐ-Ｓ６与ＣｙｃｌｉｎＤ１的表达呈正相关（ｒ＝０．７５２,Ｐ＜０．０５）。结论　ｍＴＯＲＣ１信号通路在翼状胬肉发病过程中起重要作用,并可能通过调控ＣｙｃｌｉｎＤ１的表达来实现。     

Bcl-2、bax在培养的人视网膜色素上皮细胞及视网膜前膜中的表达

原癌基因ｂｃｌ－２基因系列是目前研究较为深入的细胞凋亡相关基因之一。在正常组织ｂｃｌ－２基因的表达可能参与细胞的增生和分化，但在正常眼和人视网膜色素上皮（ｒｅｔｉｎａｌｐｉｇｍｅｎｔｅｐｉｔｈｅｌｉｕｍ，ＲＰＥ）相关眼病中的表达未见报道。增生性玻璃体...     

眼睑原发性恶性肿瘤组织P21^wafl／cipl蛋白的表达及其意义

目的：分析抑癌基因表达产物P21^wafl/cipl蛋白在眼睑原发性恶性肿瘤（Eye-lip Primary Malignant Tumor,E-LPMT)组织中的阳性表达情况。方法：采用人P21^wafl/cipl蛋白单克隆抗体,以免疫组化streptavidin biotin peroxidase complex(SP）染色方法检测眼睑原发性恶性肿瘤组织病理切片。结果：P21^wafl/cipl蛋白阳性表达于部分眼睑原发性恶性肿瘤组织细胞核中,61例患者病理切片染色后得出不同类型的眼睑原发性恶性肿瘤组织P21^wafl/cipl蛋白阳性表达率：基底细胞癌组织P21^wafl/cipl蛋白阳性表达率大于鳞状上皮癌组织P21^wafl/cipl蛋白阳性表达率（P＜0．01）;鳞状上皮癌组织P21^wafl/cipl蛋白阳性表达率大于睑板腺癌组织P21^wafl/cipl蛋白阳性表达率（P＜0．05）,且相比均有显著性差异。分化程度高的乳头状癌和囊腺癌组织P21^wafl/cipl蛋白阳性表达率大于分化程度低的结节型肿瘤组织组织P21^wafl/cipl蛋白阳性表达率（P＜0．01）。结论：抑癌基因表达产物P21^wafl/cipl蛋白阳性表达率与眼睑原发性恶性肿瘤组组织的分化程度相关。对临床治疗及预后具有指导意义。     

αB-晶状体蛋白对急性高眼压大鼠视网膜神经节细胞保护作用机制的研究

目的　研究αＢ-晶状体蛋白对钾离子通道ｋｖ１．１、ｋｖ１．３及凋亡抑制因子Ｂｃｌ-ｘｌ和凋亡因子Ｃａｓｐａｓｅ-３的影响,探讨αＢ-晶状体蛋白对急性高眼压大鼠视网膜神经节细胞（ｒｅｔｉｎａｌｇａｎｇｌｉｏｎｃｅｌｌｓ,ＲＧＣ）保护作用的机制。方法　６０只ＳＤ大鼠随机分为Ａ组（急性高眼压组）、Ｂ组（急性高眼压＋玻璃体内注射生理盐水５μＬ组）、Ｃ组（急性高眼压＋玻璃体内注射１０×１０－６ｇ?Ｌ－１αＢ-晶状体蛋白５μＬ组）,每组２０只,右眼为实验眼。注射后７ｄ和１４ｄ时,应用Ｗｅｓｔｅｒｎｂｌｏｔ和实时定量逆转录聚合酶链反应（ＱＲＴ-ＰＣＲ）法检测ｋｖ１．１、ｋｖ１．３、Ｂｃｌ-ｘｌ和Ｃａｓｐａｓｅ-３在视网膜上的表达水平。结果　注射后７ｄ和１４ｄ时,Ｃ组ｋｖ１．１、ｋｖ１．３通道蛋白和凋亡因子Ｃａｓｐａｓｅ-３蛋白表达水平和ｍＲＮＡ相对表达量均较Ａ组、Ｂ组低,差异均有统计学意义（均为Ｐ＜０.０５）;Ｃ组Ｂｃｌ-ｘｌ蛋白表达水平和ｍＲＮＡ相对表达量较Ａ组、Ｂ组高,差异均有统计学意义（均为Ｐ＜０．０５）;相同时间点不同因子Ａ组、Ｂ组间两两比较,差异均无统计学意义（均为Ｐ＞０．０５）。结论　αＢ-晶状体蛋白通过抑制急性高眼压后ＲＧＣ上钾离子通道ｋｖ１．１、ｋｖ１．３的表达,从而提高凋亡抑制因子Ｂｃｌ-ｘｌ的表达、降低凋亡因子Ｃａｓｐａｓｅ-３的表达,减少细胞凋亡,保护ＲＧＣ。     

P16和Rb在睑基底细胞癌中的表达及其意义

目的研究Ｐ１６和视网膜母细胞瘤基因（Ｒｂ）的相互关系。方法采用免疫组织化学方法观察了５０例眼部基底细胞癌中抑癌基因Ｐ１６和Ｒｂ的表达并探讨两者的相互关系。结果肿瘤标本中Ｐ１６和Ｒｂ阳性表达率分别为４８％和５２％，其中８例肿瘤组织（１６％）Ｐ１６和Ｒｂ基因均阳性表达，未见同一肿瘤组织中两者均缺失。Ｐ１６和Ｒｂ基因在基底细胞癌中的阳性表达率在肿瘤的组织分化程度方面差异显著（Ｐ＜０．０５）。结论抑癌基因Ｐ１６和Ｒｂ在基底细胞癌的产生和发展过程中起重要作用，但两者同时表达缺失较少见     

眼睑原发性恶性肿瘤组织P21~(waf1/cip1)蛋白的表达及其意义

目的:分析抑癌基因表达产物P21waf1/cip1蛋白在眼睑原发性恶性肿瘤（Eye-lip　Primary　MalignantTumor,E-LPMT）组织中的阳性表达情况。方法:采用人P21waf1/cip1蛋白单克隆抗体,以免疫组化streptavidinbiotin　peroxidase　complex（SP）染色方法检测眼睑原发性恶性肿瘤组织病理切片。结果:P21waf1/cip1蛋白阳性表达于部分眼睑原发性恶性肿瘤组织细胞核中,61例患者病理切片染色后得出不同类型的眼睑原发性恶性肿瘤组织P21waf1/cip1蛋白阳性表达率:基底细胞癌组织P21waf1/cip1蛋白阳性表达率大于鳞状上皮癌组织P21waf1/cip1蛋白阳性表达率（P<0.01）;鳞状上皮癌组织P21waf1/cip1蛋白阳性表达率大于睑板腺癌组织P21waf1/cip1蛋白阳性表达率（P<0.05）,且相比均有显著性差异。分化程度高的乳头状癌和囊腺癌组织P21waf1/cip1蛋白阳性表达率大于分化程度低的结节型肿瘤组织组织P21waf1/cip1蛋白阳性表达率（P<0.01）。结论:抑癌基因表达产物P21waf1/cip1蛋白阳性表达率与眼睑原发性恶性肿瘤组织的分化程度相关。对临床治疗及预后具有指导意义。眼科学报2001;17:206～208。     

Bcl—2基因在在角膜上皮细胞中的表达和对细胞凋亡的调控

目的：探讨ｂｃｌ－２基因对人角丰皮细胞生存过程的影响。方法：用反转灵－聚合酶链反应检测ｂｃｌ－２ ｍＲＮＪＡ在人角膜上皮细胞中的表达情况。用荧光显微镜、电镜、流式细胞仪观测ｂｃｌ－２单克隆抗体对细胞凋亡发生的影响。结果：用反转灵－聚合酶链式反应获得３３２ｂｐ的扩增带。荧光显微镜观察，十个随机视野，实验组与对照组凋亡细胞比例分别为３１．２％和１７．９％（ｕ检验，Ｐ〈０．０１）。流式细胞仪检测的结果接     

缺氧、氧化应激对视网膜色素上皮细胞增殖及葡萄糖调节蛋白78表达的影响

目的　观察缺氧、氧化应激对体外培养的视网膜色素上皮（ｒｅｔｉｎａｌｐｉｇｍｅｎｔｅｐｉｔｈｅｌｉｕｍ,ＲＰＥ）细胞增殖的影响及ＧＲＰ７８表达的变化。方法　体外培养人ＲＰＥ细胞,采用ＣｏＣｌ２诱发细胞缺氧模型、Ｈ２Ｏ２诱发氧化应激模型。实验分为量-效关系组:细胞分别经浓度为１００μｍｏｌ?Ｌ－１、２００μｍｏｌ?Ｌ－１、４００μｍｏｌ?Ｌ－１、８００μｍｏｌ?Ｌ－１的ＣｏＣｌ２、Ｈ２Ｏ２作用１２ｈ,用ＭＴＴ法检测细胞增殖情况;时-效关系组:在ＣｏＣｌ２浓度为２００μｍｏｌ?Ｌ－１、Ｈ２Ｏ２浓度为４００μｍｏｌ?Ｌ－１的基础上,分别选取药物作用８ｈ、１２ｈ、１６ｈ３个时间点收集细胞,采用免疫细胞化学染色检测ＧＲＰ７８蛋白的表达情况。结果　量-效关系组:不同浓度ＣｏＣｌ２组ＲＰＥ细胞活性与空白对照组相比均明显下降（均为Ｐ＜０．０５）;４００μｍｏｌ?Ｌ－１及８００μｍｏｌ?Ｌ－１Ｈ２Ｏ２组细胞存活率较空白对照组均明显下降（均为Ｐ＜０．０５）。时-效关系组:空白对照组ＧＲＰ７８表达阳性细胞率为（５．４±３０）％;ＣｏＣｌ２作用８ｈ、１２ｈ、１６ｈＧＲＰ７８阳性细胞率分别为（３４２±７１）％、（５４．４±９．１）％、（３４．７±６．８）％;Ｈ２Ｏ２作用８ｈ、１２ｈ、１６ｈＧＲＰ７８阳性细胞率分别为（３７．８±７１）％、（５７．４±５．１）％、（４２．５±３．９）％。经统计学分析,ＣｏＣｌ２、Ｈ２Ｏ２处理８ｈ后,ＲＰＥ细胞中ＧＲＰ７８表达均较空白对照组明显升高（均为Ｐ＜００１）,作用１２ｈ时ＧＲＰ７８的表达量最高,作用１６ｈ时ＧＲＰ７８的表达量又有下降。结论　ＧＲＰ７８可以作为ＲＰＥ细胞缺氧、氧化应激的生化标志物,ＧＲＰ７８的表达变化与细胞应激状态有一定依赖关系。     

两种缺氧模型对小鼠骨髓间充质干细胞中基质金属蛋白酶表达及其对促血管形成能力的影响

目的　观察物理和化学缺氧模型中小鼠骨髓间充质干细胞（ｂｏｎｅｍａｒｒｏｗ-ｄｅｒｉｖｅｄｍｅｓｅｎｃｈｙｍａｌｓｔｅｍｃｅｌｌｓ,ＢＭＳＣｓ）中基质金属蛋白酶１３（ｍａｔｒｉｘｍｅｔａｌｌｏｐｒｏｔｅｉｎａｓｅ-１３,ＭＭＰ-１３）的表达及其对猴脉络膜-视网膜内皮细胞ＲＦ／６Ａ管腔形成能力的影响。方法　取Ｃ５７ＢＬ／６Ｊ小鼠骨髓,培养鉴定ＢＭＳＣｓ。采用三气培养箱模拟物理缺氧及氯化钴（ＣｏＣｌ２）诱导化学缺氧。物理缺氧６ｈ、１２ｈ、２４ｈ和４８ｈ后检测ＭＭＰ-１３表达。选表达最高的处理时间,检测不同浓度ＣｏＣｌ２（０μｍｏｌ·Ｌ－１、１００μｍｏｌ·Ｌ－１、２００μｍｏｌ·Ｌ－１、３００μｍｏｌ·Ｌ－１及４００μｍｏｌ·Ｌ－１）处理后ＭＭＰ-１３表达。检测缺氧后ＢＭＳＣｓ中缺氧诱导因子-１α（ｈｙｐｏｘｉａ-ｉｎｄｕｃｉｂｌｅｆａｃｔｏｒ-１α,ＨＩＦ-１α）表达及ＢＭＳＣｓ增殖能力,观察其条件培养基诱导的ＲＦ／６Ａ管腔形成情况。结果　细胞经鉴定符合ＢＭＳＣｓ特征。物理缺氧２４ｈ后,ＭＭＰ-１３蛋白表达量达高峰（３．１６±０．２４）,较常氧组（１．００±０．１２）增加３倍（Ｐ＜０．０１）。１００μｍｏｌ·Ｌ－１和２００μｍｏｌ·Ｌ－１ＣｏＣｌ２组（１．６０±０．０９、１．６４±０．２４）中ＭＭＰ-１３表达较常氧组（１．００±０．２０）均增加（均为Ｐ＜０．０５）,而３００μｍｏｌ·Ｌ－１和４００μｍｏｌ·Ｌ－１ＣｏＣｌ２组中ＭＭＰ-１３表达与常氧组相同或稍低。三气培养箱构建的和ＣｏＣｌ２诱导的缺氧环境下培养２４ｈ后,ＢＭＳＣｓ中ＨＩＦ-１α蛋白表达较常氧组（１．００±０．２３）明显增加,相对表达量分别为３．４０±０．２６和３．１２±０．１３（均为Ｐ＜０．０１）,而两种缺氧模型间无明显差异。在培养２４ｈ时,物理缺氧组（１．５３±０．０４）和化学缺氧组（１．３１±０．１４）均较常氧组（１．０４±０．１０）细胞增殖能力增强（均为Ｐ＜０．０５）,且物理缺氧促增殖效果更明显。三气培养箱模拟的物理缺氧组、ＣｏＣｌ２诱导的化学缺氧组和常氧组ＲＦ／６Ａ管腔形成总长度分别为（５５０６±３８０）μｍ、（５１０９±５５８）μｍ和（３１２０±３００）μｍ,三气培养箱模拟的物理缺氧组和ＣｏＣｌ２诱导的化学缺氧组较常氧组均明显增加（均为Ｐ＜０．０１）,而两种缺氧模型之间差异则无统计学意义（Ｐ＞０．０５）。结论　ＣｏＣｌ２和三气培养箱均可建立缺氧模型,促进ＢＭＳＣｓ表达ＭＭＰ-１３,提高其促血管形成能力,提示缺氧可能调控ＢＭＳＣｓ表达ＭＭＰｓ进而影响新生血管发生发展。     

眼睑恶性肿瘤组织中基底膜蛋白的分布和表达及临床意义

目的　研究眼睑恶性肿瘤组织中基底膜胶原蛋白Ⅳ (typeⅣcollagen ,ColⅣ )、层粘连蛋白 (laminin ,LN)及纤连蛋白 (fibronectin ,FN)的分布和表达 ,以探讨基底膜蛋白与恶性肿瘤组织分化、转移及预后的关系。方法　应用免疫组化链霉亲和素 生物素 过氧化物酶复合物 (streptavidinbiotincomplex ,SABC)法 ,对 85例常见眼睑恶性肿瘤石蜡标本切片的基底膜进行ColⅣ、LN及FN染色 ,并检测其蛋白的表达阳性率。其中基底细胞癌 40例 ,鳞状细胞癌 2 5例 ,睑板腺癌 2 0例。结果　正常组织及良性病变组织中基底膜比较完整 ,ColⅣ、LN及FN多分布于上皮与间质交界处及动脉内膜。而肿瘤组织中基底膜则不完整或严重缺失 ,基底细胞癌、鳞状细胞癌及睑板腺癌中ColⅣ表达阳性率分别为 6 0 %( 2 4/ 40 )、6 4%( 16 / 2 5 )、40 %( 8/ 2 0 ) ;LN表达阳性率依次为 5 8%( 2 3/ 40 )、40 %( 10 / 2 5 )、35 %( 7/ 2 0 ) ;FN表达阳性率则分别为 33%( 13/ 40 )、36 %( 9/ 2 5 )、30 %( 6 / 2 0 )。随肿瘤分化程度的降低 ,表达阳性率下降 ,高分化癌与低分化癌间差异有显著意义 ( χ2 =8 2 185 ,P <0 0 5 )。随访观察 6～ 18个月 ,肿瘤复发患者 2 4例 ,其基底膜ColⅣ、LN及FN表达阳性率均明显下降 ,与无复发肿瘤患者相比 ,差异有     

眼睑肿块病理学分析477例

目的分析眼睑肿块临床和病理学特点。方法回顾性分析我院自1996年至2005年收检的477例眼睑肿块标本,所有标本均经HE染色及部分进行免疫组织化学检查。所有标本都经过病理科医师明确诊断。结果良性病变307例,包括：痣69例,乳头状瘤64例,各种囊肿57例,血管瘤23例,脂性肉芽肿23例,钙化上皮瘤19例,脂溢性角化15例,其他37例;恶性肿瘤170例,包括：基底细胞癌75例,皮脂腺癌56例,鳞状细胞癌20例,恶性淋巴瘤12例,恶性黑色素瘤5例,其他2例。较罕见病变有：囊样腺性癌、乳头状瘤恶变、汗腺腺瘤、汗腺纤维瘤及神经痣各1例,眼睑结核及神经纤维瘤各2例,畸胎瘤3例。结论眼睑肿块以良性病变多见,占64.36%;眼睑恶性肿瘤占35.64%,以基底细胞癌、皮脂腺癌和鳞状细胞癌多见。     

眼睑肿物105例临床分析

目的：探讨眼睑肿物的临床、病理学分类,为眼睑肿物的诊断和治疗提供依据。 方法：回顾性分析本院眼科近2a来收治的105例105眼眼睑肿物患者的病理学资料,对眼睑肿物的病理分类进行回顾性分析。 结果：眼睑肿物105例105眼中良性肿瘤共101例101眼,恶性肿瘤4例 4眼。良性肿瘤中占前5位的是炎性肉芽组织22例 22 眼,脂溢性角化病16例16眼,鳞状细胞乳头状瘤13例13眼,皮内痣12例12眼,表皮样囊肿12例 12 眼。恶性肿瘤中基底细胞癌2例 2眼,睑板腺癌和恶性黑色素瘤各1例1眼。 结论：明确的临床病理分型诊断有助于眼睑肿物的手术治疗及预后。     

眼睑恶性肿瘤手术31例临床分析

目的 分析探讨眼睑恶性肿瘤的诊断及手术效果。方法 分析31例31眼眼睑恶性肿瘤的一般情况、临床表现。结果 基底细胞瘤、磷状上皮癌、睑板腺癌是眼睑部位的主要恶性肿瘤。其治疗方法仍以手术为主，手术效果主要取决于手术早晚、肿瘤的大小及部位。结论 眼睑恶性肿瘤(基底细胞癌、磷状上皮癌、睑板腺癌)手术越早，肿瘤越小，效果越好。     

Clinicopathological Analysis of Malignant Eyelid Tumor Cases at Yamagata University Hospital: Statistical Comparison of Tumor Incidence in Japan and in Other Countries

Purpose

To report the clinical and histopathological features of malignant eyelid tumor cases treated in our clinic. We also compared the differences in the frequency of malignant eyelid tumor in various regions of Japan and worldwide.

Methods

Retrospectively, we studied the records of the 38 cases of malignant eyelid tumor treated in Yamagata University Hospital over the last 17 years. The statistical comparison with various countries was based on reports of case studies in those countries.

Results

Data from our clinic: Among the total of 38 cases, 15 cases (39.5%) were diagnosed as basal cell carcinoma, 11 cases (28.9%) as sebaceous gland carcinoma, and 4 cases (10.5%) as squamous cell carcinoma. In addition, three cases were malignant melanoma, two adenocarcinoma, one Merkel cell carcinoma, one malignant peripheral nerve sheath tumor, and one malignant lymphoma. The ages of patients ranged from 45 to 92 years (mean, 72.0 ± 12.4 years). Most of the cases were treated by complete resection of the tumors and eyelid reconstruction. Radiation or cryotherapy were added when required. The prognosis of the cases with basal cell carcinoma and squamous cell carcinoma was good, and that of the other tumors was relatively poor. During the same period, in Caucasians, basal cell carcinoma constituted about 80%–90% of the malignant eyelid tumors, whereas in Japan and Asian countries, basal cell carcinoma, sebaceous gland carcinoma, and squamous cell carcinoma each constituted about 20%–40%.

Conclusions

A racial difference in the incidence of basal cell carcinoma, sebaceous gland carcinoma, and squamous cell carcinoma can be considered in making a diagnosis. Jpn J Ophthalmol 2005;49:349–354 © Japanese Ophthalmological Society 2005     

MUC1 and sialoglycan expression associated with cytotoxic T lymphocyte infiltration in eyelid malignant tumors

PURPOSE: To elucidate the relation between infiltrating cytotoxic T lymphocytes and the expression of MUC1 and sialoglycans in malignant eyelid tumors. METHODS: The distribution of MUC1, Maackia amurensis lectin-II (MAL-II)-recognized sialoglycan, and CD8-positive T lymphocytes was examined histochemically in 14 patients with malignant eyelid tumors: three squamous cell carcinomas, six sebaceous gland carcinomas, and five basal cell carcinomas. The density of CD8-positive cells was examined and correlated with MUC1 and sialoglycan expression. RESULTS: MUC1 was identified in squamous cell carcinoma and sebaceous gland carcinoma, but not in basal cell carcinoma. CD8-positive cells were more densely distributed in those squamous cell and sebaceous gland carcinoma cases that were more intense in MUC1 expression and weaker in MAL-II binding. Tumors with a strong expression of both MUC1 and MAL-II-bound sialoglycans showed few CD8-positive cells. CONCLUSIONS: MUC1 with few sialoglycans is likely to induce an intense infiltration of CD8-positive cytotoxic T lymphocytes in eyelid cancers.     

Incidence of benign and malignant lesions of eyelid and conjunctival tumors

PURPOSE: To examine the incidence of benign and malignant eyelid lesions and conjunctival tumors. SUBJECTS AND METHODS: One-hundred-and twenty-eight cases (131 eyes) which were treated during the period from January 1990 to February 2004 were histopathologically diagnosed for eyelid or conjunctival tumors (87 cases of eyelid tumors and 41 cases of conjunctival tumors) in retrospective evaluations. The incidence of benign or malignant lesions, the pathological classification, age, sex, and clinical diagnostic accuracy were all investigated. RESULTS: Sixty-four (73%) of the tumors were found to be benign eyelid tumors. The common benign eyelid tumors were 14 nevocellular nevi, 9 seborrheic keratosis, 7 epidermoid cysts, and 6 papillomas. Twenty-four (27%) eyelid tumors were malignant. These included 9 basal cell carcinomas, 9 sebaceous gland carcinomas, 4 malignant lymphomas, and 2 metastatic tumors. Thirty-four (79%) conjunctival tumors were benign, and the common benign conjunctival tumors were 9 nevocellular nevi and 7 papillomas. Nine (21%) conjunctival tumors were malignant, comprising 7 malignant lymphomas and 2 squamous cell carcinomas. The mean ages of malignant eyelid and conjunctival tumor patients were significantly older than those of benign tumor patients. Clinical accuracy in predicting basal cell carcinoma and sebaceous gland carcinoma was 11.1% and 44.4%, respectively. CONCLUSIONS : Approximately 70 approximately 80% of all eyelid and conjunctival tumors are benign. Clinicians should suspect that the lesions are malignant when seeing elderly patients with eyelid or conjunctival tumors. Excised eyelid lesions should be submitted for histopathologic confirmation because there are some cases where clinical diagnosis does not match pathological diagnosis.     

眼睑肿物临床病理分析763例

目的　通过研究眼睑肿物的临床病理资料,探讨眼睑肿物的病理类型分布及临床特点。方法　收集２００３年１０月至２０１４年１月在解放军总医院眼科进行手术的７６３例眼睑肿物患者的临床病理资料,分析眼睑肿物的病理类型分布和临床特点。结果　在７６３例眼睑肿物中,良性病变６３１例,占８２．７％,恶性病变１３２例,占１７．３％。眼睑肿物良性病变前３位的病理类型是炎性病变（３０．３％）、色素痣（２７．９％）和脂溢性角化病（９．８％）。眼睑肿物恶性病变前３位的病理类型是基底细胞癌（５０．８％）、皮脂腺癌（１５．２％）和鳞状细胞癌（１２．１％）。结论　眼睑肿物中大部分为良性病变,炎性病变是最多见的病理类型,在恶性病变中基底细胞癌是最常见的病理类型。     

A retrospective study of 2228 cases with eyelid tumors

AIM: To describe the histopathologic and clinical features of eyelid tumor cases from Tianjin Eye Hospital during 2002 to 2015. METHODS: In this retrospective study, a total of 2228 cases of eyelid tumors with pathologic diagnoses were enrolled. The eyelid tumors were classified into three groups according to tumor origin: epidermal, adnexal and miscellaneous, including melanocytic, neural and vascular lesions. Inflammatory tumor-like lesions were excluded. The clinical characteristics of the eyelid tumors were analyzed, including age, gender and lesion location. RESULTS: Most eyelid tumors were epidermal in origin (1080, 48.5%), followed by miscellaneous (885, 39.7%) and adnexal tumors (263, 11.8%). Among all the tumors, 292 (13.1%) were malignant lesions, 1910 (85.7%) benign and 26 (1.1%) premalignant lesions. Most malignant tumors originated from epidermal cells (60.0%), followed by adnexal cells (34.6%). The most common malignant tumors were basal cell carcinomas (56.5%) followed by sebaceous carcinoma (34.6%), squamous cell carcinomas (3.8%) and lymphoma/plasmocytoma (1.7%). The benign and premalignant eyelid lesions mostly originated from epidermal cells (46.4%) followed by miscellaneous cell sources (45.2%), including melanocytic nevus (33.8%), seborrheic keratosis (13.7%), squamous cell papilloma (13.0%) and epidermal cysts (11.5%). CONCLUSION: Eyelid tumors are mostly epithelial in origin. Benign tumors are significantly more common than malignant tumors with an obvious female predominance, and the most frequent malignant tumor are basal cell carcinoma, sebaceous carcinoma and squamous cell carcinomas. The tumor clinical features varied among the different subtypes.